The transcriptional cycle of HIV-1 in real-time and live cells

RNA polymerase II (RNAPII) is a fundamental enzyme, but few studies have analyzed its activity in living cells. Using human immunodeficiency virus (HIV) type 1 reporters, we study real-time messenger RNA (mRNA) biogenesis by photobleaching nascent RNAs and RNAPII at specific transcription sites. Through modeling, the use of mutant polymerases, drugs, and quantitative in situ hybridization, we investigate the kinetics of the HIV-1 transcription cycle. Initiation appears efficient because most polymerases demonstrate stable gene association. We calculate an elongation rate of approximately 1.9 kb/min, and, surprisingly, polymerases remain at transcription sites 2.5 min longer than nascent RNAs. With a total polymerase residency time estimated at 333 s, 114 are assigned to elongation, and 63 are assigned to 3′-end processing and/or transcript release. However, mRNAs were released seconds after polyadenylation onset, and analysis of polymerase density by chromatin immunoprecipitation suggests that they pause or lose processivity after passing the polyA site. The strengths and limitations of this kinetic approach to analyze mRNA biogenesis in living cells are discussed.

[1]  X. Darzacq,et al.  In vivo dynamics of RNA polymerase II transcription , 2007, Nature Structural &Molecular Biology.

[2]  P. Maiuri,et al.  A real-time view of the TAR:Tat:P-TEFb complex at HIV-1 transcription sites , 2007, Retrovirology.

[3]  Maria Carmo-Fonseca,et al.  A reaction-diffusion model to study RNA motion by quantitative fluorescence recovery after photobleaching. , 2007, Biophysical journal.

[4]  Francesca Ferri,et al.  The effects of camptothecin on RNA polymerase II transcription: roles of DNA topoisomerase I. , 2007, Biochimie.

[5]  A. Knezevich,et al.  Suv39H1 and HP1γ are responsible for chromatin‐mediated HIV‐1 transcriptional silencing and post‐integration latency , 2007, The EMBO journal.

[6]  B. Peterlin,et al.  Controlling the elongation phase of transcription with P-TEFb. , 2006, Molecular cell.

[7]  Amir Kazerouninia,et al.  The conserved AAUAAA hexamer of the poly(A) signal can act alone to trigger a stable decrease in RNA polymerase II transcription velocity. , 2006, RNA.

[8]  Steven M. Block,et al.  Sequence-Resolved Detection of Pausing by Single RNA Polymerase Molecules , 2006, Cell.

[9]  N. Proudfoot,et al.  Pause Sites Promote Transcriptional Termination of Mammalian RNA Polymerase II , 2006, Molecular and Cellular Biology.

[10]  Arlen W. Johnson,et al.  The role of Rat1 in coupling mRNA 3'-end processing to transcription termination: implications for a unified allosteric-torpedo model. , 2006, Genes & development.

[11]  D. Gilmour,et al.  Pcf11 is a termination factor in Drosophila that dismantles the elongation complex by bridging the CTD of RNA polymerase II to the nascent transcript. , 2006, Molecular cell.

[12]  M. Yaniv,et al.  The human SWI/SNF subunit Brm is a regulator of alternative splicing , 2006, Nature Structural &Molecular Biology.

[13]  A. Marcello.  Latency: the hidden HIV-1 challenge , 2006, Retrovirology.

[14]  E. Cox,et al.  Real-Time Kinetics of Gene Activity in Individual Bacteria , 2005, Cell.

[15]  Michael Hampsey,et al.  A role for the CPF 3'-end processing machinery in RNAP II-dependent gene looping. , 2005, Genes & development.

[16]  Michael Feig,et al.  NTP-driven translocation and regulation of downstream template opening by multi-subunit RNA polymerases. , 2005, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[17]  Jared E. Toettcher,et al.  Stochastic Gene Expression in a Lentiviral Positive-Feedback Loop: HIV-1 Tat Fluctuations Drive Phenotypic Diversity , 2005, Cell.

[18]  Anton Meinhart,et al.  A structural perspective of CTD function. , 2005, Genes & development.

[19]  Kevin Struhl,et al.  Distinction and relationship between elongation rate and processivity of RNA polymerase II in vivo. , 2005, Molecular cell.

[20]  N. Proudfoot,et al.  Human 5′ → 3′ exonuclease Xrn2 promotes transcription termination at co-transcriptional cleavage sites , 2004, Nature.

[21]  Antonin Morillon,et al.  Gene loops juxtapose promoters and terminators in yeast , 2004, Nature Genetics.

[22]  Robert H Singer,et al.  Materials and Methods Som Text Figs. S1 to S8 References and Notes Dynamics of Single Mrnps in Nuclei of Living Cells , 2022 .

[23]  R. Pego,et al.  Analysis of binding reactions by fluorescence recovery after photobleaching. , 2004, Biophysical journal.

[24]  J. Lawrence,et al.  Repositioning of muscle-specific genes relative to the periphery of SC-35 domains during skeletal myogenesis. , 2003, Molecular biology of the cell.

[25]  M. Giacca,et al.  Regulation of HIV‐1 gene expression by histone acetylation and factor recruitment at the LTR promoter , 2003, The EMBO journal.

[26]  A. Kornblihtt,et al.  A slow RNA polymerase II affects alternative splicing in vivo. , 2003, Molecular cell.

[27]  M. Giacca,et al.  Recruitment of human cyclin T1 to nuclear bodies through direct interaction with the PML protein , 2003, The EMBO journal.

[28]  Robert H. Singer,et al.  Single mRNA Molecules Demonstrate Probabilistic Movement in Living Mammalian Cells , 2003, Current Biology.

[29]  Hiroshi Kimura,et al.  The transcription cycle of RNA polymerase II in living cells , 2002, The Journal of cell biology.

[30]  T. Misteli,et al.  A Kinetic Framework for a Mammalian RNA Polymerase in Vivo , 2002, Science.

[31]  W. Greene,et al.  Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy , 2002, Nature Medicine.

[32]  A. Jordan,et al.  The site of HIV‐1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation , 2001, The EMBO journal.

[33]  M. Rosbash,et al.  A block to mRNA nuclear export in S. cerevisiae leads to hyperadenylation of transcripts that accumulate at the site of transcription. , 2001, Molecular cell.

[34]  M. Giacca,et al.  Multiple Modes of Transcriptional Regulation by the HIV‐1 Tat Transactivator , 2001, IUBMB life.

[35]  D. Eick,et al.  Conditional Expression of RNA Polymerase II in Mammalian Cells , 2000, The Journal of Biological Chemistry.

[36]  J. Mcneil,et al.  Tracking COL1A1 RNA in osteogenesis imperfecta. splice-defective transcripts initiate transport from the gene but are retained within the SC35 domain. , 2000 .

[37]  T. Misteli,et al.  High mobility of proteins in the mammalian cell nucleus , 2000, Nature.

[38]  K. Jeang,et al.  Multifaceted Activities of the HIV-1 Transactivator of Transcription, Tat* , 1999, The Journal of Biological Chemistry.

[39]  J. R. Coleman,et al.  Processing of Endogenous Pre-mRNAs in Association with SC-35 Domains Is Gene Specific , 1999, The Journal of cell biology.

[40]  A. Marcello,et al.  Inducible expression of herpes simplex virus thymidine kinase from a bicistronic HIV1 vector. , 1998, Research in virology.

[41]  F S Fay,et al.  Visualization of single RNA transcripts in situ. , 1998, Science.

[42]  Ping Wei,et al.  A Novel CDK9-Associated C-Type Cyclin Interacts Directly with HIV-1 Tat and Mediates Its High-Affinity, Loop-Specific Binding to TAR RNA , 1998, Cell.

[43]  N. Proudfoot,et al.  The HIV‐1 5′ LTR poly(A) site is inactivated by U1 snRNP interaction with the downstream major splice donor site , 1997, The EMBO journal.

[44]  N. Proudfoot,et al.  Poly(A) site selection in the HIV-1 provirus: inhibition of promoter-proximal polyadenylation by the downstream major splice donor site. , 1995, Genes & development.

[45]  H. Klamut,et al.  The human dystrophin gene requires 16 hours to be transcribed and is cotranscriptionally spliced , 1995, Nature Genetics.

[46]  B. Graveley,et al.  CPSF recognition of an HIV-1 mRNA 3'-processing enhancer: multiple sequence contacts involved in poly(A) site definition. , 1995, Genes & development.

[47]  D. Peabody,et al.  Mutations that increase the affinity of a translational repressor for RNA. , 1994, Nucleic acids research.

[48]  E. Fenyö,et al.  Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1 , 1990, Journal of virology.

[49]  J. Steitz,et al.  The U3 small nucleolar ribonucleoprotein functions in the first step of preribosomal RNA processing , 1990, Cell.

[50]  S. Le,et al.  The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA , 1989, Nature.

[51]  O. Uhlenbeck,et al.  An RNA mutation that increases the affinity of an RNA-protein interaction. , 1987, Nucleic acids research.

[52]  A. Greenleaf,et al.  A mutation in the largest subunit of RNA polymerase II alters RNA chain elongation in vitro. , 1985, The Journal of biological chemistry.

[53]  D. Soumpasis.  Theoretical analysis of fluorescence photobleaching recovery experiments. , 1983, Biophysical journal.